GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus
- Conditions
- First Posted Date
- 2005-10-19
- Last Posted Date
- 2018-03-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 600
- Registration Number
- NCT00241605
- Locations
- 🇨🇦
GSK Investigational Site, Québec, Canada
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers
- Conditions
- Interventions
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 79
- Registration Number
- NCT00240526
- Locations
- 🇹🇭
GSK Investigational Site, Bangkok, Thailand
Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Tositumomab and/or Iodine I 131 Tositumomab
- Conditions
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2015-11-11
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 150
- Registration Number
- NCT00240591
Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2012-08-13
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 93
- Registration Number
- NCT00240565
- Locations
- 🇨🇦
GSK Investigational Site, Quebec, Canada
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
- Conditions
- Interventions
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2015-04-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 646
- Registration Number
- NCT00240630
- Locations
- 🇺🇸
GSK Investigational Site, Seattle, Washington, United States
Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT00240539
- Locations
- 🇹🇭
GSK Investigational Site, Bangkok, Thailand
Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2016-12-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 109
- Registration Number
- NCT00240500
- Locations
- 🇹🇭
GSK Investigational Site, Bangkok, Thailand
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
- Conditions
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2017-01-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 640
- Registration Number
- NCT00240643
- Locations
- 🇬🇧
GSK Investigational Site, York, United Kingdom
Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks
- Conditions
- Interventions
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 623
- Registration Number
- NCT00240617
- Locations
- 🇺🇸
GSK Investigational Site, Wenatchee, Washington, United States
Patients With Low-Grade Non-Hodgkin's Lymphoma Previously Treated With Iodine I 131 Tositumomab
- Conditions
- First Posted Date
- 2005-10-18
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 88
- Registration Number
- NCT00240578